Polyamines and the NMDA receptor: Modifying intrinsic activities with aromatic substituents

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 11, 2006, Pages 2837-2841

  Berger, Michael L ^a   Bitar, Abdallah Y ^b   Waitner, Matthew J ^b   Rebernik, Patrick ^a   O'Sullivan, Mary C ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CANISIUS COLLEGE   (United States)

Author keywords

3H MK 801 binding; Aromatic substituents; NMDA receptor; Spermidine; Spermine

Indexed keywords

AROMATIC COMPOUND; DIZOCILPINE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POLYAMINE DERIVATIVE; SPERMIDINE DERIVATIVE; SPERMINE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HIPPOCAMPUS; IC 50; NONHUMAN; RAT;

ANIMALS; MOLECULAR STRUCTURE; POLYAMINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 33646030245     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.03.015     Document Type: Article

References (24)

1. Williams K. Biochem. J. 325 (1997) 289
2. Kemp J.A., and McKernan R.M. Nat. Neurosci. Suppl. 5 (2002) 1039
3. Berger M.L., and Noe C.R. In: Ramchandran U. (Ed). Current Topics in Medicinal Chemistry Vol. 3 (2003), Research Trends, Poojapura 51-64
4. Benveniste M., and Mayer M.L. J. Physiol. 464 (1993) 313
5. Chao J., Seiler N., Renault J., Kashiwagi K., Masuko T., Igarashi K., and Williams K. Mol. Pharmacol. 51 (1997) 861
6. Igarashi K., Shirahata A., Pahk A.J., Kashiwagi K., and Williams K. J. Pharmacol. Exp. Ther. 283 (1997) 533
7. Berger M.L., Schödl C., and Noe C.R. Eur. J. Med. Chem. 33 (1998) 3
8. Berger M.L., Rebernik P., Bitar A., and O'Sullivan M. FENS Abstr. 1 (2002) A0771
9. O'Sullivan M.C., and Zhou Q. Bioorg. Med. Chem. Lett. 5 (1995) 1957
10. O'Sullivan M.C., Dalrymple D.M., and Zhou Q. J. Enzyme Inhibit. 11 (1996) 97
11. O'Sullivan M.C., Zhou Q., Li Z., Durham T.B., Rattendi D., Lane S., and Bacchi C.J. Bioorg. Med. Chem. 5 (1997) 2145
12. Li Z., Fennie M.W., Ganem B., Hancock M.T., Kobaslija M., Rattendi D., Bacchi C.J., and O'Sullivan M.C. Bioorg. Med. Chem. Lett. 11 (2001) 251
13. Pandey S., Fletcher K.A., Baker S.N., Baker G.A., DeLuca J., Fennie M.F., and O'Sullivan M.C. J. Photochem. Photobiol. A 162 (2004) 387
14. O'Sullivan M.C., and Dalrymple D.M. Tetrahedron Lett. 36 (1995) 3451
15. Bernatowicz M.S., Wu Y., and Matsueda G.R. Tetrahedron Lett. 34 (1993) 3389
16. Abdel-Magid A.F., Carson K.G., Harris B.D., Maryanoff C.A., and Shah R.D. J. Org. Chem. 61 (1996) 3849
17. 3H]MK-801 (5.0 nM) was incubated in 10 mM Tris-acetate buffer for 3 h in the presence of glutamate and glycine (10 μM each) with membranes prepared from rat hippocampus or cerebral cortex. Bound ligand was separated by filtration. For nonspecific binding, the channel-opening co-agonists glutamate and glycine were replaced by their respective antagonists d-2-amino-5-phosphonopentanoic acid (100 μM) and 5,7-dichlorokynurenic acid (10 μM, both from Tocris Bioscience).
18. Mukhin A., Kovaleva E.S., and London E.D. J. Pharmacol. Exp. Ther. 282 (1997) 945
19. Pöhler, T., Schadt, O., Niepel, D., Rebernik, P., Berger, M. L., Noe, C. R. Eur. J. Med. Chem. (in press).
20. Williams K. J. Pharmacol. Exp. Ther. 266 (1993) 231
21. Bergeron R.J., Weimar W.R., Wu Q., Feng Y., and McManis J.S. J. Med. Chem. 39 (1996) 5257
22. Donkor I.O., Assefa H., Rattendi D., Lane S., Vargas M., Goldberg B., and Bacchi C. Eur. J. Med. Chem. 36 (2001) 531
23. Donkor I.O., and Berger M.L. Bioorg. Med. Chem. Lett. 7 (1997) 1455
24. Sharma T.A., Carr A.J., Davis R.S., Reynolds I.J., and Hamilton A.D. Bioorg. Med. Chem. Lett. 8 (1998) 3459